65,437 trials
Partial Edentulism
Primary: Evaluation of Changes in Crestal Bone Levels Evaluated From Standardized Periapical X-rays Comparing the Immediate and Delayed Loading Procedures in Each Group. — 0.82…
Ventricular Fibrillation · Ventricular Flutter · Sudden Cardiac Death
Primary: Number of Participants With Severe Intra-operative Complications at ICD Implant and/or Events at Follow up — 18; 16 Participants
Organ Transplantation
Primary: Number of Organs Recovered Per Donor — 3.79; 3.60 organs recovered per donor — p=0.38
Meibomian Gland Dysfunction · Posterior Blepharitis
Primary: Ocular Surface Disease Index — 56.6; 46.4; 48.4 units on a scale
Hepatocellular Carcinoma (HCC)
Primary: Safety of a Combination Therapy — 0 participants
Coronary Artery Disease
Primary: Difference in FFR Between IV Adenosine and IV Regadenoson — 0.84; 0.84 ratio (Pd/Pa)
Lung Neoplasms
Primary: Progression-free Survival — 12.78; 11.17 Months — p=0.0891
Surgical Site Infection Following Cesarean Delivery
Primary: Cesarean Surgical Site Infection — 18; 21; 21; 15 Participants
Nervous Restlessness
Primary: Change of Symptom Inner Restlessness (Pre - Post) — 137; 3; 6 participants
Hydrocele · Inguinal Hernia
Primary: FLACC: Face, Legs, Activity, Cry, and Consolability Pain Assessment Scale (FLACC) — 0; 0 units on a scale
Lung Cancer
Primary: Maximum Dose of Erlotinib When Given Together With Carboplatin, Paclitaxel, and Thoracic Conformal Radiotherapy (Phase I [Closed to Accrual as of 1/3/2008]) — 0; 0; 2 DLTs
Hypothermia · Newborn
Primary: Number of Infants With Axillary Temperature <36.0 Degrees Celsius — 55; 56 Participants
Cocaine Related Disorders
Primary: Longest Duaration of Achieved Abstinance — 0; 7; 1; 8 number of participants
Chronic Kidney Disease
Primary: Anti-Erythropoietin (EPO) Antibodies — 1.7 percentage of participants
Shoulder Joint Disease · Complications; Arthroplasty · Intraoperative Complications
Primary: Total Blood Loss — 1122.4; 1472 Total Blood Loss (mL)